Evaluation of thyroid nodules classified as Bethesda category III on FNAC

BACKGROUND: The Bethesda (BSRTC) category III has been ascribed a malignancy rate of 5–15%, however, the probability of malignancy remains variable. AIM: To evaluate category III with respect to its rate and risk of malignancy and substratify it. SETTINGS AND DESIGN: Atypia of undetermined significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Shiwani, Naik, Leena P, Kothari, Kanchan S, Fernandes, Gwendolyn C, Agnihotri, Mona A, Gokhale, Jagruti C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259932/
https://www.ncbi.nlm.nih.gov/pubmed/28182068
http://dx.doi.org/10.4103/0970-9371.197590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259932/
https://www.ncbi.nlm.nih.gov/pubmed/28182068
http://dx.doi.org/10.4103/0970-9371.197590

Ejemplares similares